Thus, the authors hypothesize that SARS-CoV-2 contains a large number of purU-rich sequences and can potentially hyperactivate TLR8-mediated inflammation, resulting in the marked elevations of TNF-ɑ, IL-6, fibrinogen, and blood viscosity observed in severe COVID-19. This evidence concerns the gene TNF and COVID-19.